Fortitude Advisory Group’s Astera Labs ALAB Stock Holding History

Fortitude Advisory Group’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,999	Closed	-$927K	–	224
2024 Q4	$927K	Buy	+6,999	New	+$657K	0.56%	30

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fortitude Advisory Group's ALAB Position: Q1 2025 in Review

Fortitude Advisory Group sold out of Astera Labs (ALAB) in Q1 2025, closing a stake of 6,999 shares — an estimated $927K sold.

Fortitude Advisory Group first reported a position in ALAB in Q4 2024 and held it in 1 quarter. The position peaked at $927K in Q4 2024. 389 funds tracked by Wall St. Rank hold ALAB as of Q1 2025.

Fortitude Advisory Group reported no remaining Astera Labs position as of Q1 2025 after selling out during the quarter.
Fortitude Advisory Group sold 6,999 Astera Labs shares in Q1 2025, an estimated $927K.
Fortitude Advisory Group first reported a position in Astera Labs in Q4 2024 and held it in 1 quarter.
Fortitude Advisory Group's Astera Labs position peaked at $927K in Q4 2024.
389 funds tracked by Wall St. Rank held Astera Labs as of Q1 2025.

Based on Fortitude Advisory Group's 13F filing for Q1 2025, filed 17 Apr 2025.